PRESTIGE: PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort

Overview

The PRESTIGE-registry is a joint effort at 9 European heart centers to collect data regarding patients presenting with stent thrombosis in a dedicated database. There will be extensive clinical and procedural characterization, furthermore blood platelet function testing, intracoronary imaging, DNA-sampling and analysis of thrombus aspiration will be performed.

Full Title of Study: “PREvention of Stent Thrombosis by an Interdisciplinary Global”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 2015

Detailed Description

Rationale: Stent Thrombosis (ST) is a serious complication of percutaneous coronary intervention (PCI) with stent implantation. Previous studies have been hampered by small sample size, in particular regarding the number of patients with late and very late ST and patients with DES thrombosis, and by incomplete patient characterisation, particularly concerning intracoronary imaging and blood platelet function data. Objective: to identify novel predictors and to observe clinical outcome after an episode of ST, with the use of state-of-the-art new techniques such as OCT/IVUS, platelet function testing, genetic analysis. Study design: multicenter matched case control study Study population: Cases: all patients presenting with definite ST. Expected number of patients to be included: 2000 Controls: patients undergoing PCI will be matched based on the following criteria: Expected number of patients to be matched: 2000 1. who underwent a PCI for the same indication 2. who underwent a PCI on the same date (±5 days) 3. who underwent a PCI in the same interventional centre Main study parameters/endpoints: clinical, ECG, biochemical, angiographic, procedural, haematological, histopathological, genetic, OCT/IVUS-imaging, and follow-up characteristics Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Prior to PCI, 50 ml of whole blood will be drawn from all patients. Primary PCI for ST will be performed according to institutional best practise. During PCI, performance of Optical Coherence Tomography and/or Intravascular Ultrasound is encouraged. Thrombus aspiration is performed when indicated. During hospitalisation, all patients will be asked to fulfil a questionnaire regarding possible triggering mechanisms that might have provoked the ST. Patients will be asked to visit the patient clinic for platelet function 30 days after the acute phase of the ST. Finally, patients will be contacted for follow-up details.

Clinical Trial Outcome Measures

Primary Measures

  • to identify novel factors responsible for the occurence of stent thrombosis
    • Time Frame: 3 years

Participating in This Clinical Trial

Inclusion Criteria

  • patients presenting with stent thrombosis Exclusion Criteria:

  • patients refusing informed consent

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Universitaire Ziekenhuizen KU Leuven
  • Collaborator
    • Deutsches Herzzentrum Muenchen
  • Provider of Information About this Clinical Study
    • Principal Investigator: Prof Dr Walter Desmet, prof. dr. W. Desmet, KULeuven, Belgium and prof. T. Gerschlick, University Hospital Leicester, UK, University Hospitals Leuven, Belgium – University Hospital, Gasthuisberg
  • Overall Official(s)
    • Walter Desmet, MD, PhD, Principal Investigator, Dept. of Cardiology, University Hospitals Leuven, Belgium
    • Tony Gershlick, MD, PhD, Principal Investigator, Div. of Cardiology, Glenfield Hospital, Leicester, United Kingdom
    • Adnan Kastrati, MD, PhD, Study Chair, German Heart Institute, Munich, Germany
    • Steffen Massberg, MD, PhD, Study Chair, German Heart Institute, Munich, Germany
    • Tom Adriaenssens, MD, Study Director, Dept. of Cardiology, University Hospitals Leuven, Belgium
    • Wouter van Werkum, MD, PhD, Study Director, Dept. of Cardiology, St Antonius Hospital Nieuwegein, the Netherlands
  • Overall Contact(s)
    • Walter Desmet, MD, PhD, +32 16 34 24 66, sic@uzleuven.be

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.